Return On Equity in % of AVADEL PHARMACEUTICALS PLC from Q1 2014 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
AVADEL PHARMACEUTICALS PLC quarterly/annual Return On Equity history and change rate from Q1 2014 to Q3 2025.
  • AVADEL PHARMACEUTICALS PLC Return On Equity for the quarter ending 30 Sep 2025 was 23.4 %.
  • AVADEL PHARMACEUTICALS PLC annual Return On Equity for 2024 was -65.7 %, a 68.9% increase from 2023.
  • AVADEL PHARMACEUTICALS PLC annual Return On Equity for 2023 was -212 %, a 93% increase from 2022.
  • AVADEL PHARMACEUTICALS PLC annual Return On Equity for 2022 was -3K %, a 4099% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

AVADEL PHARMACEUTICALS PLC Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 23.4 +117 01 Jul 2025 30 Sep 2025
Q2 2025 -3.73 +119 +97% 01 Apr 2025 30 Jun 2025
Q1 2025 -36.1 +113 +75.9% 01 Jan 2025 31 Mar 2025
Q4 2024 -65.7 +146 +68.9% 01 Oct 2024 31 Dec 2024
Q3 2024 -93.3 +234 +71.5% 01 Jul 2024 30 Sep 2024
Q2 2024 -123 +677 +84.7% 01 Apr 2024 30 Jun 2024
Q1 2024 -150 -905 -120% 01 Jan 2024 31 Mar 2024
Q4 2023 -212 +2.79K +93% 01 Oct 2023 31 Dec 2023
Q3 2023 -328 +122 +27.1% 01 Jul 2023 30 Sep 2023
Q2 2023 -800 -565 -241% 01 Apr 2023 30 Jun 2023
Q1 2023 756 +858 01 Jan 2023 31 Mar 2023
Q4 2022 -3K -2.93K -4099% 01 Oct 2022 31 Dec 2022
Q3 2022 -450 -398 -776% 01 Jul 2022 30 Sep 2022
Q2 2022 -234 -196 -516% 01 Apr 2022 30 Jun 2022
Q1 2022 -103 -99.4 -2919% 01 Jan 2022 31 Mar 2022
Q4 2021 -71.5 -76.6 -1493% 01 Oct 2021 31 Dec 2021
Q3 2021 -51.3 -68.8 -394% 01 Jul 2021 30 Sep 2021
Q2 2021 -38.1 -84.6 -182% 01 Apr 2021 30 Jun 2021
Q1 2021 -3.41 -205 -102% 01 Jan 2021 31 Mar 2021
Q4 2020 5.13 -154 -96.8% 01 Oct 2020 31 Dec 2020
Q3 2020 17.5 -715 -97.6% 01 Jul 2020 30 Sep 2020
Q2 2020 46.6 +1.03K 01 Apr 2020 30 Jun 2020
Q1 2020 201 +481 01 Jan 2020 31 Mar 2020
Q4 2019 159 +322 01 Oct 2019 31 Dec 2019
Q3 2019 732 +782 01 Jul 2019 30 Sep 2019
Q2 2019 -984 -981 -38030% 01 Apr 2019 30 Jun 2019
Q1 2019 -280 -314 -901% 01 Jan 2019 31 Mar 2019
Q4 2018 -163 -249 -290% 01 Oct 2018 31 Dec 2018
Q3 2018 -50.2 -169 -142% 01 Jul 2018 30 Sep 2018
Q2 2018 -2.58 -76.3 -103% 01 Apr 2018 30 Jun 2018
Q1 2018 34.9 +54.5 01 Jan 2018 31 Mar 2018
Q4 2017 85.9 +168 01 Oct 2017 31 Dec 2017
Q3 2017 118 +67.4 +132% 01 Jul 2017 30 Sep 2017
Q2 2017 73.7 01 Apr 2017 30 Jun 2017
Q1 2017 -19.6 01 Jan 2017 31 Mar 2017
Q4 2016 -82.4 01 Oct 2016 31 Dec 2016
Q3 2016 51.1 01 Jul 2016 30 Sep 2016
Q2 2015 -170 +4.95 +2.83% 01 Apr 2015 30 Jun 2015
Q1 2015 -130 +424 +76.5% 01 Jan 2015 31 Mar 2015
Q4 2014 -170 01 Oct 2014 31 Dec 2014
Q3 2014 -126 01 Jul 2014 30 Sep 2014
Q2 2014 -175 01 Apr 2014 30 Jun 2014
Q1 2014 -554 01 Jan 2014 31 Mar 2014

AVADEL PHARMACEUTICALS PLC Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -65.7 +146 +68.9% 01 Jan 2024 31 Dec 2024
2023 -212 +2.79K +93% 01 Jan 2023 31 Dec 2023
2022 -3K -2.93K -4099% 01 Jan 2022 31 Dec 2022
2021 -71.5 -76.6 -1493% 01 Jan 2021 31 Dec 2021
2020 5.13 -154 -96.8% 01 Jan 2020 31 Dec 2020
2019 159 +322 01 Jan 2019 31 Dec 2019
2018 -163 -249 -290% 01 Jan 2018 31 Dec 2018
2017 85.9 +168 01 Jan 2017 31 Dec 2017
2016 -82.4 01 Jan 2016 31 Dec 2016
2014 -170 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.